Latest BioPharma News and In-Depth Analysis | BioPharma BoardRoom

19 June, 2025 | Thursday

BetaLife and A*STAR Collaborate to Develop Next Generation Cell-based Therapy for Diabetes Treatment

BetaLife has acquired the rights to human iPSC technology and cell lines from A*STAR BetaLife and A*STAR sign research collaboration agreement to jointl...

March 27, 2023 | Monday | News

18
19
20
21
22
23
24
25
26
27

Partner Content

Precision Medicine in Asia: From Genomics to Oncology Impact
11 April, 2025
BIO CEO John F. Crowley Warns of Lasting Damage if Pharma Tariffs Move Forward
08 April, 2025
Croda Strengthens Executive Team with Appointment of Stephen Oxley as CFO and Dr. Thomas Riermeier as President of Life Sciences
01 April, 2025
WuXi Biologics CEO Dr. Chris Chen Projects Accelerated Growth in 2025 After Solid 2024 Performance
26 March, 2025
Aragen Strengthens Leadership with Key Appointments in Drug Discovery and Chemical Development
10 March, 2025
Belén Garijo Leads Merck Back to Profitable Growth, Delivering Strong 2024 Performance
06 March, 2025
Emergent BioSolutions CEO Joe Papa Reports Strong Adjusted EBITDA Growth in 2024, Forecasts Continued Profitability in 2025
04 March, 2025
Merck KGaA Ushers in New Leadership Era with Key Executive Appointments
18 February, 2025

BioPharma BreakThrough's

Editor Picks

President Trump Signs Executive Order to Lower Drug Prices, Focuses on Medicare Negotiations and Pharmacy Benefit Manager Reforms
18 April, 2025
BIO CEO John F. Crowley Warns of Lasting Damage if Pharma Tariffs Move Forward
08 April, 2025
WuXi Biologics CEO Dr. Chris Chen Projects Accelerated Growth in 2025 After Solid 2024 Performance
26 March, 2025
Trump Administration Cuts 10,000 Federal Health Jobs, Sparking National Outcry
02 April, 2025
Trump Administration Takes Bold Step to Withdraw U.S. from World Health Organization
21 January, 2025

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

Gene Editing Breakthroughs

Innovative Drug Discovery

Vaccine Development

Biologics and Therapeutic Antibodies

× Please select an option to participate in the poll.

View poll results More polls

× You have successfully cast your vote.

{{ optionDetail.option }} {{ optionDetail.percentage }}%

More polls

About Us Media Pack Contact Us Privacy Policy

© 2025 Biopharma Boardroom. All Rights Reserved.